Skip to main content
Equibles

Spruce Street Capital LP

Position in NERV — Minerva Neurosciences, Inc.

CIK 2050194 NEW YORK, NY
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,188,025
-$786,362 QoQ
Shares Held
1,655,500
0.0% QoQ
Ownership
3.47%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#11
of 58 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Spruce Street Capital LP holds $397,390,268 across 24 Biotechnology names. NERV ranks #14 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RLAY
Relay Therapeutics, Inc.
 2,984,125 $55,832,978
2 LBRX
Lb Pharmaceuticals Inc
 1,376,159 $44,663,240
3 RLMD
Relmada Therapeutics, Inc.
 6,391,328 $44,227,989
4 ANRO
Alto Neuroscience, Inc.
 1,353,047 $35,706,910
5 DNTH
Dianthus Therapeutics, Inc. /DE/
 354,816 $34,587,463
6 SVRA
Savara Inc
 3,452,576 $21,267,868
7 PCVX
Vaxcyte, Inc.
 306,047 $17,790,512
8 ELVN
Enliven Therapeutics, Inc.
 329,006 $16,697,054

All Filings in NERV

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,188,025 1,655,500
2026-03-31 $9,974,387 1,655,500
2025-12-31 $6,655,110 1,655,500